+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years - 80Years
All Genders
ID07117227

Study to Validate a New Prediction Model for Kidney Cancer Treatment and Outcomes Including Patients With Venous Tumor Thrombus Using Real-World Data and Risk-Based Treatment Comparison

Led by Peking University Third Hospital · Updated on 2026-04-14

4700

Participants Needed

1

Research Sites

25 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are conducting a single-center observational study using real-world data from 4700 patients with renal cell carcinoma RCC, including those with venous tumor thrombus VTT, treated at Peking University Third Hospital. The study aims to develop and validate a new prognostic prediction model for RCC patients, compare its performance against existing models, and assess whether risk-stratified treatment based on this model can improve survival outcomes using an emulated target trial approach. The study includes two main groups patients receiving treatment aligned with the risk stratification from the new prediction model, and those whose treatment does not follow this stratification. Treatments evaluated include model-guided adjuvant therapies initiated within 12 weeks after surgery or no adjuvant treatment during follow-up before disease progression. Data is collected retrospectively from 2012 to 2025 and prospectively from 2025 to 2026, covering clinical, laboratory, imaging, pathology, and treatment information. Participants undergo follow-up visits and telephone check-ins based on European Association of Urology guidelines until events such as recurrence, death, withdrawal, or study completion. Researchers monitor survival, disease recurrence, quality of life, and healthcare resource use. The primary outcome is disease-free survival measured up to 48 months from follow-up start to recurrence, second primary cancer, death, or other events. Data quality assurance and statistical analyses are performed to evaluate model performance and treatment effects.

CONDITIONS

Brief Title

Validation of RCC Predicting Model With Emulated-target Trial

Research Team

J

Jiyuan Chen, master

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here